Poliovirus type 1 strain LS-a [PV1(LS-a)] is a PV variant adapted to mice by multiple passages through mouse and monkey tissues. To investigate the molecular basis underlying mouse neurovirulence of PV1(LS-a), a cDNA of the viral genome containing nucleotides 112 to 7441 was cloned, and the nucleotide sequence was determined. Compared with that of the mouse avirulent progenitor PV1(Mahoney), 54 nucleotide changes were found in the genome of the PVI(LS-a) virus, resulting in 20 amino acid substitutions in the virus polyprotein. Whereas the nucleotide changes were scattered throughout the genome, the amino acid substitutions were largely clustered in the capsid proteins and, to a certain extent, in the virus proteinase 2APr'. By in vitro mutagenesis, PVl(LS-a)-specific capsid mutations were introduced into a cDNA clone of PVI(Mahoney). We show that neither the individual amino acid mutations nor combinations of mutations in the region encoding VP1 conferred to PV1(Mahoney) the mouse-adapted phenotype of PV1(LS-a). Chimeric cDNA studies demonstrated that a recombinant type 1 virus containing the PVI(LS-a) sequence from nucleotide 2470 to nucleotide 3625 displayed a neurovirulent phenotype in mice. Further dissection of this region revealed that mouse neurovirulence of PV1(LS-a) was determined by multiple mutations in regions encoding both viral proteinase 2APr' and capsid protein VP1. The mouse neurovirulent viruses, PV1(LS-a), W1-M/LS-Pf [nucleotides 496 to 3625 from PVI(LS-a)], and W1-MILS-NP [nucleotides 2470 to 3625 from PV1(LS-a)], showed increased sensitivity to heat treatment at 45°C for 1 h. Surprisingly, the thermolabile phenotype was also displayed by a recombinant of PV1(Mahoney) carrying a PVI(LS-a) DNA fragment encoding the N-terminal portion of 2APr'. This suggests that base substitutions in the region encoding 2APr' affected capsid stability, thereby contributing to the neurovirulence of the virus in mice.
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Enigmatic in studies of the pathogenesis of poliovirus (PV) is the mechanism by which mouse-adapted strains cause neurologic symptoms in mice. These strains cannot infect any cultured rodent cells, such as mouse L cells, unless the cells have been transformed with cDNAs (16, 24) or with the gene (3) specifying the human PV receptor (hPVR). Apparently, the mouse homolog of hPVR cannot replace that receptor for the mouse-adapted PV (27) . Therefore, at least at the level of cell culture, the barrier to infection resides in the absence of a suitable cell surface protein facilitating uptake of the mouseadapted virus. When injected intraspinally or intracerebrally, however, these strains may kill the mouse, although they do not cause the typical syndrome of poliomyelitis (8a) .
PV is the prototype virus of the genus Enterovirus of the family Picomaviridae. It is a small, nonenveloped plus-strand RNA virus. The icosahedral particle consists of 60 copies each of the capsid proteins VP1, VP2, VP3, and VP4. The three largest molecules (VP1 to VP3) form the outer surface, while VP4 is a capsid-internal protein (13) . The genome of PV is a single copy of single-stranded RNA of plus-strand polarity encoding a single polypeptide, the polyprotein (Fig. 1A) (15, 34) . The polyprotein is processed by virus-encoded proteinases into numerous polypeptides, including the capsid-specific proteins VPO (the precursor to VP4 and VP2), VP3, and VP1 (15, 32) . Except for the "maturation cleavage" of VPO (10) , proteolytic processing is catalyzed by the proteinases 2Aprm, 3Cpro, and 3CDprO (8, 11) . The coding region for 2Apr, maps directly adjacent to the capsid protein region P1 (Fig. 1A) , and, indeed, 2APro cleaves the polyprotein cotranslationally into the structural (P1) and nonstructural (P2 and P3) polypeptides (12, 31, 41) .
PV exists in three serotypes (PV1, PV2, and PV3). All three are able to cause poliomyelitis in humans or, after experimental infection, in monkeys. The narrow host range is determined by the specificity of the interaction between hPVR (4, 16, 24) or its monkey homolog (17) with the poliovirion. These receptors, whose normal function is unknown, are immunoglobulin-like polypeptides consisting of three extracellular domains (V-C2-C2). They perform a dual function in PV infection: attachment of the virus to the cell surface and destabilization of the virion, leading to the formation of A particles (7) . The genetics of expression of the PVR gene, resulting in the synthesis of several splice variants, is complex, and the distribution of the receptor protein(s) in human tissue, as a determinant of viral tissue tropism, is poorly understood (43 (14) . An exception may be MEF 1, a type 2 PV (PV2) strain reported to be mouse neurovirulent without extended prior passage in mouse brain (39) . Other PV2 strains were adapted to proliferate in the mouse central nervous system (CNS), the best known being PV2(Lansing) [PV2(L)] (2) . In 1953, Li and Schaeffer reported the isolation of a mouse-adapted, neurovirulent strain of PV type 1 [PV1(LS-a)] (20) .
Attempts to decipher the determinants of mouse neurovirulence of PV have yielded a very complex pattern. These experiments have followed a strategy to convert PV1(Mahoney) [PV1(M)], a wild-type strain that does not cause apparent disease in mice, to the mouse neurovirulent phenotype (mn), either by genetic exchange of gene segments between PV1(M) and PV2(L) (23, 29) or by passage in the CNS of mice (6, 28) . mn PV1(M) variants were obtained by the exchange of a limited number of amino acids in a loop well exposed at the surface of the virion (BC loop of VP1) (23, 29) or, remarkably, as the result of single-amino-acid exchanges in VP1 or VP2 internal to the capsid (6, 28 (38) . The recombinants between PV1(M) and PV1(LS-a) were constructed by exchanging the corresponding DNA fragments digested with common restriction enzymes. Point mutations were generated in subclones either by PCR of the corresponding sequence from the PV1(LS-a) cDNA or by site-directed mutagenesis that used uridineenriched single-strand DNA (19) . After sequence analysis, the mutated DNA fragments were cloned back into the full-length cDNA clone.
Plaque assay. The infectivity of all of the virus stocks was titrated by plaque assay on HeLa R19 cell monolayers seeded on six-well plates. Serial dilutions (10-fold) of virus stocks were made with phosphate-buffered saline. Three hundred microliters of each dilution was applied to the monolayer and then adsorbed at room temperature for 30 min. The cells were then overlaid with 1.4% Noble agar containing 5% fetal bovine Wl.V1056I
PVI ( 30 ,ul of purified virus suspended in phosphate-buffered saline. The injected mice were observed daily for 3 weeks for paralysis and death. The 50% lethal dose of the viruses was determined by injecting serially (10-fold) diluted virus and was calculated as described by Reed and Muench (35) .
RESULTS
Nucleotide sequence of the genome of PV1(LS-a). PV1(M), albeit highly virulent in primates, is avirulent in rodents. However, repeated passage of the virus in monkey tissues as well as in mouse CNS resulted in the emergence of PV1(LS-a), one of the few PV1 strains that caused disease in mice (20) . The plaque phenotype of the PV1(LS-a) virus assayed on HeLa cells was slightly smaller than that of PV1(M) (Fig. 2) , but the virus grew in cultured cells to a level comparable to that of PV1(M) (data not shown). There were no apparent differences observed in cleavage patterns of PV1(LS-a) polyprotein, and that was true particularly for the processing of the capsid P1 precursor and the composition of the virion proteins (data not shown). The 50% lethal dose of a plaque-purified isolate of PV1(LS-a) was found to be 106.9 PFU (Fig. 1B) . To analyze the molecular basis underlying the mouse-adapted phenotype of this virus, a cDNA clone was generated from the genomic RNA of PV1(LS-a). The cDNA was sequenced from nt 113 to the 3' end of the genome. A total of 54 nt substitutions (13 transversions and 41 transitions) accumulated in the virus genome during mouse adaptation. Twenty of these yielded amino acid changes (Table 1) . Whereas the base changes were scattered throughout the genome, the amino acid substitutions were largely clustered in the region encoding the capsid proteins and the virus proteinase 2Apro. Moreover, approximately 50% of the amino acid changes were specific for PV1(LS-a); the rest could also be found in PV1(Sabin) and some other strains. It is noteworthy that five of six PV1(LS-a)-specific capsid amino acid changes occurred in VP1, the most exposed protein of the capsid proteins. In addition, four base changes were identified in the 5' nontranslated region that was sequenced in this study. Among these, the mutations at nt 140 and 189 were located in the 5'-terminal region of the internal ribosomal entry site, a cis-acting genetic element of picornavirus that confers cap-and 5' end-independent translation of the virus mRNA (44) . It is not clear if these point mutations in the internal ribosomal entry site would affect virus RNA translation inside the mouse CNS; however, they appeared to have no effect on virus growth in cultured HeLa cells (data not shown). Furthermore, a guanosine-to-adenosine change at nt 4124 resulted in a cleavage site mutation (Gln-Gly-*Gln-Ser) at the border between the virus polypeptides 2B and 2C, in contrast to a Gln-Gly pair found at this cleavage site of all the other PV strains.
PV1(LS-a)-specific mutations that accumulated in VP1 were not sufficient to confer the mouse neurovirulent (mn) phenotype. The nucleotide sequence of the PV1(LS-a) cDNA revealed a cluster of PV1(LS-a)-specific mutations yielding amino acid changes in capsid protein VP1 (Table 1) . Most of these mutations were located either in the exposed surface loops on the apexes of the virion or close to the canyon, a depressed structure surrounding the fivefold axis of symmetry (Table 2 ). This canyon is the likely receptacle for hPVR (37) . To determine whether any of these mutations could produce the mn phenotype, mutant PV1(M) clones bearing corresponding amino acid changes were constructed by site-directed mutagenesis. The resulting viruses were tested with Swiss Webster mice via an intracerebral route. Surprisingly, none of the point mutants caused any apparent disease in mice (Fig.  1B) . To examine the possibility that these mutations additively contribute to the mn phenotype, a construct combining all five of the PV1(LS-a)-specific capsid mutations was engineered. However, the combination of the mutations did not increase mouse neurovirulence either (Fig. 1B) . As will be shown below, recombinant viruses containing PV1(LS-a)-specific sequences of VP1 or the entire P1 failed to cause paralysis in mice, an observation suggesting that PV1(LS-a) capsid mutations by themselves were not sufficient to confer mouse neurovirulence for PV1 (see viruses W1-M/LS-NB in Fig. 3B and W1-M/LS-PB in Fig. 3A) . However, the capsid mutations did play a role in mouse infectivity, since chimeric PV containing PV1(LS-a) 2A '  2545  2585  2645  2784  2879  2906  3135  3163  3171  3228   A  A  G  A  C  A  A  T  C  C   2A  3445  3460  3492  3514  3594   C  T  G  A  A   2B  3896, 3898  3931  4003 (Fig. 3B) . We therefore conclude that the mouse neurovirulence of PV1(LS-a) was determined by mutations from two loci: the region encoding the viral capsid protein VP1 and the region encoding viral proteinase 2APro.
Thermostability of the wild-type and chimeric viruses. PV1(M) is relatively resistant to inactivation at 45°C. We were interested in determining whether the mutations that accumulated during multiple passages in monkey tissue and mouse CNS influenced the thermostability of PV1(LS-a). In this study, wild-type PV1(M), PV1(LS-a), and a series of Mahoney/ LS-a chimeric viruses were incubated at 45°C for 1 h, and the residual infectivities were examined by plaque assay. Untreated control samples were assayed at the same time. As shown in Fig. 4 , the titer of PV1(M) was reduced by approximately 1 log during heat treatment, whereas that of PV1(LS-a) lost approximately 5 logs of infectivity, a result indicating that PV1(LS-a) was highly thermolabile. In general, the virus variants expressing the mn phenotype were also thermolabile (LS-a, M/LS-PF, and M/LS-NP), and these variants all contained the 82Apro segment harboring the five PV1(LS-a)-specific mutations. Analysis of the nonneurovirulent variants revealed the surprising result that the increased thermolability correlated with the presence or absence of the PV1(LS-a)-specific 82Apro segment (M/LS-BP versus -NB, -NN, or -NS). Specifically, W1-M/LS-BP, a virus whose genotype is like that of PV1(M) except for the PV1(LS-a)-specific gene segment encoding 2Apro, lost 5 logs of infectivity within 1 h at 45°C. It appears that the numerous mutations in the PV1(LS-a) capsid proteins had little effect on the sensitivity of the virion to heat. This suggests that the increased thermolability of PV1(LS-a) may result from specific RNA-protein interactions destabilizing the virus capsid.
DISCUSSION
Wild-type strains of PV are neurovirulent in transgenic mice expressing hPVR (18, 36) . For virologists, the explanation for the extended host range is straightforward because the mn phenotype is not related to an altered genotype of the virus but is related to that of the host. In contrast, adaptation of PV strains to express an mn phenotype in normal mice is due to genetic changes of the virus. It now appears that with every genetic analysis of independently isolated mouse-adapted PV strains, the phenomenon of mouse neurovirulence is rendered more complicated. Even more complex are the disease syndromes produced by these PV variants, because none of them causes typical poliomyelitis in normal mice (8a) .
Original analyses of the mouse-adapted strain PV2(L) mapped mn determinants to the BC loop of VP1 (23, 29) , a well-exposed structure located near the fivefold axis above the canyon of the virion (Fig. 5) . The VP1 BC loop is a neutralization antigenic site (N-AgIa) (25) , while the canyon is considered to be the receptacle for the receptor (37) The numerous mutations in the capsid proteins of the mouse-adapted strain PV1(LS-a), however, are not sufficient 8/12 to produce the mn phenotype (Fig. 1B and Fig. 3 proteolytic processing of the polyprotein catalyzed by proteinase 3CP"0 or 3CDPro occurs at Gln-Gly amino acid pairs (8, 11) . The only other exception reported so far is a cleavage site tchdemonstrating between polypeptides 2C and 3A in PV2(W-2), which is also a ict the chimeric the capsid mutations in a protomer is shown in Fig. 5 . Approximately 30% of these, almost all of which are PV1 (LS-a) specific, are located on the virion surface; the rest are more or less internally positioned, including one mutation mapping to the internal capsid protein VP4. Some structural implications of the PV1(LS-a)-specific VP1 mutations are summarized in Table 2 . Mutation V-1056-I is located near the threefold axis of symmetry, adjacent to residue E-1054. A single mutation (E-1054->G) has recently been reported to produce an mn phenotype in PV1(M) (28) , an observation that contrasts with the V-1056-I mutation identified here that had no effect. D-1102-->G, T-1143--A, and P-1250-*L mapped to the surface of the apexes (Fig. 5) within or in the vicinity of the BC loop (N-AgIa), a site that can determine mouse neurovirulence (see above). The A-1231--V mutation is located on the rim of the canyon and may influence binding to the unknown mouse receptor. Although the mutations found in PV1(LS-a) VP1 by themselves are not sufficient to produce the mn phenotype, they are necessary because they act in conjunction with downstream sequences (in 2APro). The most interesting result of the study presented here is the apparent involvement of the coding sequence of 2AP"r in mouse neurovirulence of PV1(LS-a). As mentioned, the PV1 (LS-a) 2APro sequence harbors three amino acid changes, a large fraction of the mutations mapping to the nonstructural regions (Table 1) . Of the three amino acid changes, the Y-70---C mutation is unusual because Tyr-70 of 2Apro is conserved among all sequenced strains of PV. PV proteinase 2APro has been implicated in several different processes of replication: cleavage of the structural from the nonstructural proteins of the polyprotein (8, 11, 41) ; inhibition of host cell protein synthesis (40) ; transactivation of translation (9) , possibly by binding to the internal ribosomal entry site elements (22) ; and RNA replication (26) . It is conceivable that the mutations in PV1(LS-a) 2APr" created a protein with altered properties affecting any of the 2APro functions mentioned above (or hitherto uncovered functions) and that such altered properties influenced the mn phenotype. On the other hand, the PV1(LS-a) mutations in 2APr" per se were not sufficient to confer the mn phenotype to PV1(M), but they rendered this virus extremely thermolabile (Fig. 4) . We consider it possible, therefore, that specific interactions between the RNA sequence specifying 2APro and the capsid proteins exist and that a modification of these interactions by point mutations destabilizes the virus, thereby contributing to the mouse neurovirulence of PV1(LS-a). If 
